Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
Kutluk
Tezer
T
Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. tkutluk@tr.net
Kurne
Ogün
O
Akyüz
Canan
C
Ceyhan
Mehmet
M
Kanra
Güler
G
Büyükpamukçu
Münevver
M
Seçmeer
Gülten
G
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000175:diagnosis / Q000382:microbiology; D000077723:Cefepime; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D019348:Empiricism; D005260:Female; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008297:Male; D000077731:Meropenem; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D013810:Therapeutic Equivalency; D013845:Thienamycins / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D016179:Granulocyte Colony-Stimulating Factor; D000077723:Cefepime; D000077731:Meropenem